ArticleKidney international reports2026

Modelled CKD Benefits of Broad Sodium-Glucose Cotransporter-2 Inhibitor Eligibility in the UK.

Navdeep Tangri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.